Pro and con for systematic screening for prostate cancer in Denmark - a review article.

Systematic PSA-based screening for prostate cancer remains controversial due to the trade-off between reduced mortality and risk of overdiagnosis and overtreatment. Adding new tools like magnetic-resonance-imaging-targeted biopsies and genetic marker…

Preview only. Read the full abstract at the source